Insider Transactions Reported by 10 Insiders of ENDRA Life Sciences Inc.

Symbol
NDRA on Nasdaq
Location
Ann Arbor, MI

There are no Buy or Sell transactions made by insiders since 26 Feb 2025

ENDRA Life Sciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anthony DiGiandomenico Director $1,691,146 21 Jan 2026
Alexander Y. Tokman Chief Executive Officer, Director $379,525 21 Jan 2026
Michael Harsh Director $332,492 21 Jan 2026
Lou Basenese Director $332,487 21 Jan 2026
Richard Jacroux Chief Financial Officer $101,200 21 Jan 2026
Michael Milos Thornton Chief Technology Officer $56,329 18 May 2023
Renaud Bertrand Maloberti Chief Commercial Officer 28 Mar 2022
UBS Group AG Market maker/broker-dealer 27 Aug 2024
Francois Roger Michelon Chief Executive Officer, Director 30 Jan 2023
Irina Pestrikova Senior Director, Finance 30 Jan 2023

Recent Insider Transactions by Companies or Individuals for ENDRA Life Sciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.